Results 171 to 180 of about 1,668 (203)
Some of the next articles are maybe not open access.
2005
Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder that usually manifests in the early fifties and progresses relentlessly with a mean survival of 9 years. Clinically, MSA is dominated by autonomic/urogenital failure which may be associated with either levodopa unresponsive parkinsonism in 80p.cent of cases (MSA-P subtype) or with ...
G K, Wenning, F, Geser
openaire +2 more sources
Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder that usually manifests in the early fifties and progresses relentlessly with a mean survival of 9 years. Clinically, MSA is dominated by autonomic/urogenital failure which may be associated with either levodopa unresponsive parkinsonism in 80p.cent of cases (MSA-P subtype) or with ...
G K, Wenning, F, Geser
openaire +2 more sources
Progressive cerebral atrophy in multiple system atrophy
Journal of the Neurological Sciences, 2002Nine patients with multiple system atrophy (MSA) were studied based on MRI findings of cerebral hemispheric involvement. The age at onset was 56.4+/-8.6 (mean+/-S.D.) years, duration of illness at the first MRI study 2.1+/-1.1 years, duration of illness at the last study 9.7+/-2.6 years, and the follow-up duration 7.6+/-2.3 years.
Masaaki, Konagaya +4 more
openaire +2 more sources
Survival in multiple system atrophy
Movement Disorders, 2008AbstractWe here report survival in patients with multiple system atrophy (MSA) in a large, prospectively studied group of patients with MSA. Eighty‐five of 100 patients were known to have died. Three patients were rediagnosed as having PD. Twenty‐four patients came to autopsy, which showed MSA in 22 and idiopathic Parkinson's disease in 2.
Anette, Schrag +3 more
openaire +2 more sources
Pain in multiple system atrophy
Journal of Neurology, 1996Pain is a recognized feature of idiopathic Parkinson's disease (IPD) but has never been studied in multiple system atrophy (MSA), the commonest cause of atypical parkinsonism. We retrospectively analysed histories of pain in 100 consecutive cases of clinically probable MSA.
F, Tison +5 more
openaire +2 more sources
Young-onset multiple system atrophy
Journal of the Neurological Sciences, 2012Han-Joon Kim +2 more
exaly +4 more sources
Current Opinion in Neurology, 1998
Although the precise definition of multiple system atrophy has been difficult, a recent consensus in diagnostic criteria for multiple system atrophy has been achieved. This should lead to progress in defining the underlying pathophysiology of the neuroendocrine, autonomic and motor deficits characteristic of multiple system atrophy.
openaire +2 more sources
Although the precise definition of multiple system atrophy has been difficult, a recent consensus in diagnostic criteria for multiple system atrophy has been achieved. This should lead to progress in defining the underlying pathophysiology of the neuroendocrine, autonomic and motor deficits characteristic of multiple system atrophy.
openaire +2 more sources
Multiple system atrophy: An update
Movement Disorders, 2003Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder that usually manifests in the early sixth decade of life and progresses relentlessly with a mean survival of 9 years. Clinically, MSA is dominated by autonomic/urogenital failure, which may be associated with either levodopa (L-dopa) -unresponsive parkinsonism in 80% of cases (MSA-P
Gregor K, Wenning +3 more
openaire +2 more sources
2007
Publisher Summary This chapter deals with the epidemiology, clinical features, pathological characteristics, diagnostic evaluation, and treatment approaches for multiple system atrophy (MSA). MSA is regarded as a distinct disease process with a complex combination of clinical presentations.
openaire +2 more sources
Publisher Summary This chapter deals with the epidemiology, clinical features, pathological characteristics, diagnostic evaluation, and treatment approaches for multiple system atrophy (MSA). MSA is regarded as a distinct disease process with a complex combination of clinical presentations.
openaire +2 more sources
Sleep Dysfunction in Multiple System Atrophy
Current Treatment Options in Neurology, 2012Sleep disorders in multiple system atrophy (MSA) are common manifestation and include reduced and fragmented sleep, excessive daytime sleepiness, REM sleep behaviour disorder (RBD), and sleep-disordered breathing. Of these, RBD is the most common (affecting 90 %-100 % of patients with MSA) and is regarded as a red flag for MSA.
FERINI STRAMBI , LUIGI, Marelli S.
openaire +3 more sources
An update on multiple system atrophy
Current Opinion in NeurologyPurpose of review Multiple system atrophy (MSA) is a rapidly progressive synucleinopathy characterized by autonomic failure, parkinsonism, and cerebellar ataxia. Here, we provide an update on α-synuclein's role in MSA pathophysiology and review the new Movement Disorders Society (MDS) diagnostic criteria and the utility of α ...
Iva, Stankovic +2 more
openaire +2 more sources